Appetite and body weight regulation after bariatric surgery von Münzberg, H, Laque, A, Yu, S, Rezai‐Zadeh, K, Berthoud, H.‐R

Volltext

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphom... von Soussain, C., Choquet, S., Blonski, M., Leclercq, D., Houillier, C., Rezai, K., Bijou, F., Houot, R., Boyle, E., Gressin, R., Nicolas-Virelizier, E., Barrie, M., Moluçon-Chabrot, C., Lelez, M.L., Clavert, A., Coisy, S., Leruez, S., Touitou, V., Cassoux, N., Daniau, M., Ertault de la Bretonnière, M., El Yamani, A., Ghesquières, H., Hoang-Xuan, K.

Volltext

Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery von Hao, Z, Münzberg, H, Rezai-Zadeh, K, Keenan, M, Coulon, D, Lu, H, Berthoud, H-R, Ye, J

Volltext

Endovascular Thrombectomy in the Elderly: Do Radiological and Clinical Outcomes Differ from Those in Younger Patients? A Prospective Single-Center Experience von Rezai, Mehdi K., Advani, Rajiv, Dalen, Ingvild, Fjetland, Lars, Kurz, Kathinka D., Kurz, Martin W.

Volltext

Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus von Hayden, M. K, Rezai, K, Hayes, R. A, Lolans, K, Quinn, J. P, Weinstein, R. A

Volltext

Myths and facts about getting an academic faculty position in neuroscience von Hsu, Nina S., Rezai-Zadeh, K. Paul, Tennekoon, Michael S., Korn, Stephen J.

Volltext

Optical quenching and recovery of photoconductivity in single-crystal diamond von Chen, J., Lourette, S., Rezai, K., Hoelzer, T., Lake, M., Nesladek, M., Bouchard, L.-S., Hemmer, P., Budker, D.

Volltext

Are IPL home devices really foolproof? von Schmitt, L., Rezai, K., Karsai, S.

Volltext

A magnetic trap for high-field seeking neutron spin states von Brenner, Th, Chesnevskaya, S., Fierlinger, P., Geltenbort, P., Gutsmiedl, E., Lauer, T., Rezai, K., Rothe, J., Zechlau, T., Zou, R.

Volltext

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients von Fajac, A, Gligorov, J, Rezai, K, Lévy, P, Lévy, E, Selle, F, Beerblock, K, Avenin, D, Saintigny, P, Hugonin, S, Bernaudin, J-F, Lokiec, F

Volltext

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors von Massard, C, Soria, J.C, Stathis, A, Delord, J.P, Awada, A, Peters, S, Lewin, J, Bekradda, M, Rezai, K, Zeng, Z, Azher, H, Perez, S, Siu, L

Volltext

Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production von Arendash, G.W., Schleif, W., Rezai-Zadeh, K., Jackson, E.K., Zacharia, L.C., Cracchiolo, J.R., Shippy, D., Tan, J.

Volltext

469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma von Ouafik, L, Berenguer, C, Cayol, M, Astorgues-Xerri, L, Bekradda, M, Odore, E, Rezai, K, Riveiro, M.E, Cvitkovic, E

Volltext

587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines von Odore, E, Astorgues-Xerri, L, Bekradda, M, Cvitkovic, E, Herait, P, Lokiec, F, Rezai, K, Riveiro, M

Volltext

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cance... von Lokiec, F, Bonneterre, J, Italiano, A, Varga, A, Campone, M, LeSimple, T, Leary, A, Dieras, V, Rezai, K, Giacchetti, S, Proniuk, S, Bexon, A, Gilles, E, Bisaha, J, Zukiwski, A, Cottu, P

Volltext

Schizophrenia and Cognitive Dysmetria: A Positron-Emission Tomography Study of Dysfunctional Prefrontal--Thalamic--Cerebellar Circuitry von Andreasen, Nancy C., O'Leary, Daniel S., Cizadlo, Ted, Arndt, Stephan, Rezai, Karim, Laura L. Boles Ponto, Watkins, G. Leonard, Hichwa, Richard D.

Volltext

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies von Stathis, A, Quesnel, B, Amorim, S, Thieblemont, C, Zucca, E, Raffoux, E, Dombret, H, Peng, Y, Palumbo, A, Vey, N, Thomas, X, Michallet, M, Gomez-Roca, C, Recher, C, Karlin, L, Yee, K, Rezai, K, Preudhomme, C, Facon, T, Herait, P

Volltext

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study von Berthon, Céline, MD, Raffoux, Emmanuel, MD, Thomas, Xavier, MD, Vey, Norbert, Prof, Gomez-Roca, Carlos, MD, Yee, Karen, MD, Taussig, David Christopher, MD, Rezai, Keyvan, PhD, Roumier, Christophe, PharmD, Herait, Patrice, MD, Kahatt, Carmen, MD, Quesnel, Bruno, Prof, Michallet, Mauricette, Prof, Recher, Christian, Prof, Lokiec, François, ScD, Preudhomme, Claude, Prof, Dombret, Hervé, Prof

Volltext

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2 von Brain, E, Isambert, N, Dalenc, F, Diéras, V, Bonneterre, J, Rezai, K, Jimenez, M, Mefti-Lacheraf, F, Cottura, E, Tresca, P, Vanlemmens, L, Mahier-Aït Oukhatar, C, Lokiec, F, Fumoleau, P

Volltext

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study von Amorim, Sandy, MD, Stathis, Anastasios, MD, Gleeson, Mary, FRCPath, Iyengar, Sunil, MD, Magarotto, Valeria, MD, Leleu, Xavier, Prof, Morschhauser, Franck, Prof, Karlin, Lionel, MD, Broussais, Florence, MD, Rezai, Keyvan, ScD, Herait, Patrice, MD, Kahatt, Carmen, MD, Lokiec, François, PhD, Salles, Gilles, Prof, Facon, Thierry, Prof, Palumbo, Antonio, Prof, Cunningham, David, Prof, Zucca, Emanuele, MD, Thieblemont, Catherine, Prof

Volltext